MDCalc

Pulmonary Embolism Severity Index (PESI)

Predicts 30-day outcome of patients with pulmonary embolism.

years
Sex
History of cancer
History of heart failure
History of chronic lung disease
Heart rate ≥110
Systolic BP <100 mmHg
Respiratory rate ≥30
Temperature <36°C/96.8°F
Altered mental status (disorientation, lethargy, stupor, or coma)
O2 saturation <90%

Result:

Please fill out required fields.
Advice
  • Social determinants of health should be taken into account before considering outpatient management (including access to anticoagulants and prompt follow-up care for further workup and management, typically within 7 days). 
  • Given low mortality of low risk PE, outpatient management would save significant healthcare costs over hospitalization (~5000 EUR per avoided admission per Ghazvinian et al, 2020).  
  • For those determined to be very low risk (score ≤ 65), all studies showed a 30-day mortality of <2%; in the first validation, low risk (Class I and II) had a 90-day mortality of 1.1%. 
  • A non-inferiority trial demonstrated Class I and II could have been treated as outpatients assuming no other medical or social issues.
Management
  • If the patient is considered very low (≤ 65) or low risk (66-85) by the PESI score:
    • They have an overall low risk of mortality or severe morbidity.
    • Consider outpatient management of PE if clinically appropriate and social factors allow for it.
  • If the patient is considered intermediate (86-105), high (106-125), or very high risk (>125):
    • They have an overall high risk of mortality and severe morbidity.
    • Consider higher levels of care (e.g., ICU) for those with higher scores.
Critical Actions
  • Renal failure or patients with other significant comorbidities should be considered separately as these patients were not included in the validation study.

  • PESI poorly predicts morbidity/mortality in intermediate risk groups.

  • CT angiography-measured parameters can be superior to PESI in predicting 30-day mortality.

  • Pro-BNP levels, RV function, and the presence of right-heart thrombus may also affect a patient's risk assessment.